These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16573367)

  • 1. New frontiers for cardiac risk assessment: C-reactive protein.
    Martin CM; Almond J
    Consult Pharm; 2006 Mar; 21(3):188-91, 195-6, 205-6. PubMed ID: 16573367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Guijarro C
    Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum.
    Ridker PM
    Circulation; 2002 Jun; 105(22):2583-5. PubMed ID: 12045159
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.
    Monroe VS; Kerensky RA; Rivera E; Smith KM; Pepine CJ
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):23S-30S. PubMed ID: 12644337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy.
    Yu H; Rifai N
    Clin Biochem; 2000 Nov; 33(8):601-10. PubMed ID: 11166006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein: the pawn has been promoted to queen.
    Yeh ET; Palusinski RP
    Curr Atheroscler Rep; 2003 Mar; 5(2):101-5. PubMed ID: 12573194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does JUPITER change the daily routine of our practice?].
    Schlossberg D
    Praxis (Bern 1994); 2009 Mar; 98(6):302. PubMed ID: 19291635
    [No Abstract]   [Full Text] [Related]  

  • 8. C-reactive protein and cardiovascular diseases--is it ready for primetime?
    Lavie CJ; Milani RV; Verma A; O'Keefe JH
    Am J Med Sci; 2009 Dec; 338(6):486-92. PubMed ID: 20010156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members.
    Di Napoli M; Schwaninger M; Cappelli R; Ceccarelli E; Di Gianfilippo G; Donati C; Emsley HC; Forconi S; Hopkins SJ; Masotti L; Muir KW; Paciucci A; Papa F; Roncacci S; Sander D; Sander K; Smith CJ; Stefanini A; Weber D
    Stroke; 2005 Jun; 36(6):1316-29. PubMed ID: 15879341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiinflammatory effects of statins.
    McCullough PA
    N Engl J Med; 2001 Oct; 345(16):1209; author reply 1210-1. PubMed ID: 11642241
    [No Abstract]   [Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus.
    Pfützner A; Forst T
    Diabetes Technol Ther; 2006 Feb; 8(1):28-36. PubMed ID: 16472048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, antiinflammatory drugs, and quality of life in diabetes.
    Cummings DM; King DE; Mainous AG
    Ann Pharmacother; 2003 Nov; 37(11):1593-7. PubMed ID: 14565804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation.
    Kereiakes DJ
    Circulation; 2003 Oct; 108(16 Suppl 1):III22-7. PubMed ID: 14605016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke.
    Ridker PM
    Circulation; 2003 Sep; 108(12):e81-5. PubMed ID: 14504253
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
    Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
    Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of inflammation and their clinical significance.
    Ballantyne CM; Nambi V
    Atheroscler Suppl; 2005 May; 6(2):21-9. PubMed ID: 15823493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins.
    Nash DT
    J Natl Med Assoc; 2005 Dec; 97(12):1600-7. PubMed ID: 16396052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory biomarkers and statins.
    Blanco-Colio LM; Tuñón J; Martín-Ventura JL; Egido J
    Drugs Today (Barc); 2005 Mar; 41(3):171-7. PubMed ID: 15883614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of statin therapy using high-sensitivity C-reactive protein as an indicator of coronary heart disease risk.
    Nambi V; Ballantyne CM
    Curr Atheroscler Rep; 2005 Feb; 7(1):22-8. PubMed ID: 15683598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.